Form 483

VertiFlex, Inc. Form 483, 2008-10-07

FDA issued a Form 483 to VertiFlex, Inc. on 2008-10-07 with 11 public-safe observations.

483· Form 483 issued11 observations

VertiFlex, Inc. · San Clemente, United States · Issued October 7, 2008

Overview

  • 11 public-safe observations are available for this inspection.
  • 11 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

7 Oct 2008
21 CFR 803.17

Lack of Written MDR Procedures

Cited by Scott K Zika

7 Oct 2008
21 CFR 820.20(e)

Quality System Procedures

Cited by Scott K Zika

7 Oct 2008
21 CFR 820.30(g)

Design validation acceptance criteria

Cited by Scott K Zika

7 Oct 2008
21 CFR 820.50

Purchasing controls, Lack of or inadequate procedures

Cited by Scott K Zika

7 Oct 2008
21 CFR 820.70(a)

Process control procedures

Cited by Scott K Zika

Inspected site

VIVertiFlex, Inc.San Clemente, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 803.17Cited across public-safe Form 483 observations1x
21 CFR 820.100(a)Cited across public-safe Form 483 observations1x
21 CFR 820.100(a)(3)Cited across public-safe Form 483 observations1x
21 CFR 820.150(a)Cited across public-safe Form 483 observations1x
21 CFR 820.20(e)Cited across public-safe Form 483 observations1x
21 CFR 820.30(g)Cited across public-safe Form 483 observations1x
21 CFR 820.50Cited across public-safe Form 483 observations1x
21 CFR 820.70(a)Cited across public-safe Form 483 observations1x
21 CFR 820.72(a)Cited across public-safe Form 483 observations1x
21 CFR 820.72(b)(2)Cited across public-safe Form 483 observations1x
21 CFR 820.80(a)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 11 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere